bitcoins technology Top Related searches

Peter Orsag, CEO of Lazard Financial Consultant: Geopolitical concerns are bringing more downside risks.It's a mystery to say "no" to the influx of large amounts of funds, and the public offering products are setting off a wave of "restricted purchases". Whether it is an active equity fund, a debt-based fund or QDII fund, many outstanding products have recently announced the suspension of large-scale subscription, and even some funds have chosen to directly adjust the subscription threshold to 0 yuan and suspend all subscription operations. Some insiders said that there is another mystery for fund companies to suspend large-scale subscriptions. As the end of the year approaches, the market gradually enters the stage of differentiation. At this time, the purchase restriction is likely to come from the consideration that the fund manager hopes that the capital side will be more stable. (CSI)Euronext: Due to an accident in the waterway, the delivery point along the Mosel River of the February 2025 rapeseed futures (COMG5) contract will be unavailable until further notice.

Robin Hood, a online celebrity brokerage, managed assets of $195 billion in November. In November, the stock exchange was $147.1 billion.Robin Hood, a online celebrity brokerage, managed assets of $195 billion in November. In November, the stock exchange was $147.1 billion.According to informed sources, Stada Arzneimittel AG, a pharmaceutical company focusing on consumer health care, sounded out investors' interest before the German IPO. The company may raise about 1.5 billion euros ($1.6 billion) through an IPO.

Trump's NASA candidate called his future SpaceX mission a "question mark". On Wednesday, Jared Isaacman, a billionaire in science and technology, who was selected by President-elect Trump, said that his planned private astronaut mission with Musk's SpaceX company "may be put on hold" because he was ready to enter the government to lead NASA.Morgan Stanley downgraded Hikvision to equal rating, with a target price of RMB in 36 yuan. Andy Meng, an analyst at Morgan Stanley, was previously rated as over-matched. The target price is 36 yuan RMB, which is up by 14%.According to informed sources, Stada Arzneimittel AG, a pharmaceutical company focusing on consumer health care, sounded out investors' interest before the German IPO. The company may raise about 1.5 billion euros ($1.6 billion) through an IPO.